title: Progressive licensing needs progressive open debate.
authors.forename: Paul C
authors.initials: PC
authors.lastname: Hébert
authors.forename: Matthew
authors.initials: M
authors.lastname: Stanbrook
authors.forename: Barbara
authors.initials: B
authors.lastname: Sibbald
authors.forename: Ken
authors.initials: K
authors.lastname: Flegel
authors.forename: Noni
authors.initials: N
authors.lastname: MacDonald
authors.forename: Amir
authors.initials: A
authors.lastname: Attaran
mesh_terms: D002170:Canada; D003142:Communication; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry; D004335:Drug and Narcotic Control / Q000458:organization & administration*; D006801:Humans; D008004:Licensure / Q000331:legislation & jurisprudence; D011358:Product Surveillance, Postmarketing